Taurine Eye Drops May Prevent the Progression of Cataract
- Registration Number
- NCT06639711
- Lead Sponsor
- University Of Anbar
- Brief Summary
The aim of the current intervention study is to determine the effectiveness of taurine containing eye drops (available under brand name VIZILOTON) to prevent the progression of grade I and II senile cataract.
This study could answer:
* Dose continuous use of taurine-containing eye drops could prevent further deterioration of vision in mild cases of cataract?
* The acceptance/ compliance of participants to taurine-containing eye drops.
* Could long-term use of taurine-containing eye drops cause adverse effect(s)?
Participants will:
* Take taurine-containing eye drops (VIZILOTON eye drops) 4 times a day for one year.
* Visit eye clinic every 3 months for assessment and visual examination.
* Keep notes for their symptoms and their adherence to treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 50
- The presence of grade I or II senile cataract on one or two eyes.
- clinical signs of glaucoma
- history of amblyopia, eye surgery, argon or YAG laser eye treatment, or major eye trauma
- history of iritis, retinal crystalline deposits, or optic nerve disease
- visually significant fundus pathology
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Application of Taurine-containing Eye Drops Taurine -
- Primary Outcome Measures
Name Time Method Visual Acuity 1 Year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Al-Nahrain Eye Clinics
🇮🇶Ramadi, Anbar, Iraq